Shopping Cart
Remove All
Your shopping cart is currently empty
DHFR-IN-17 (compound j9) is an orally active SaDHFR inhibitor with an IC50 value of 0.97 nM. It exhibits antibacterial activity against Staphylococcus aureus, with a minimum inhibitory concentration of 0.031 μg/mL.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | DHFR-IN-17 (compound j9) is an orally active SaDHFR inhibitor with an IC50 value of 0.97 nM. It exhibits antibacterial activity against Staphylococcus aureus, with a minimum inhibitory concentration of 0.031 μg/mL. |
| In vivo | DHFR-IN-17 (compound j9), when administered orally at doses of 2, 5, or 10 mg/kg for three consecutive days, helps alleviate skin infection damage in C57 mice caused by MRSA induction. |
| Formula | C17H21IN4O2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.